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manifestations. One hallmark feature of the disease is acromegalic cardiomyopathy; a 
syndrome of progressive cardiac dysfunction characterized by left ventricular (LV) 
hypertrophy, diastolic dysfunction, and combined systolic and diastolic dysfunction in 
advanced stages. Dilated cardiomyopathy (DCM) is relatively rare in this setting but is 
associated with increased mortality.  
Case report. We report the case of a 44 y.o man who was admitted to the cardiology 
department because of progressive dyspnea on exertion and paroxysmal nocturnal dyspnea 
with recent onset. Physical examination revealed systolic murmurs in mitral and tricuspid areas 
and jugular vein distension. Laboratory findings showed moderate hepatic cytolysis. 
Electrocardiogram showed sinus rhythm (SR) and LV hypertrophy. Echocardiography 
revealed DCM with severe LV dysfunction (LV ejection fraction (LVEF) = 20%), LV 
hypertrophy, restrictive diastolic dysfunction, biatrial enlargement, moderate mitral 
regurgitation and pulmonary hypertension (systolic pulmonary artery pressure (PAPs) = 60 
mmHg). A coronary angiography was performed to rule out coronary disease. It revealed 
normal coronary arteries. Optimal heart failure (HF) treatment was started. The patient did not 
attend follow-up visits. Ten years later, he presented with NYHA class III HF symptoms. 
Mandibular enlargement with widened space between the lower incisor teeth, macroglossia, 
enlargement of his hands and feet over the last 10 years was noted on physical examination. 
Laboratory findings revealed hepatic cytolysis and elevated NT-proBNP (9668 pg/ml). 
Electrocardiogram identified atrial fibrillation. Echocardiography showed dilated 
cardiomyopathy with further deterioration of LV function (LVEF=15%) and pulmonary 
hypertension. Magnetic resonance imaging showed non-specific LV myocardial fibrosis. 
Genetic tests, carried out to exclude a genetic DCM (170 genes evaluated), did not identify any 
pathogenic variants. At this point an endocrinology evaluation was requested. It revealed active 
acromegaly (IGF-I = 416 ng/ml) due to pituitary microadenoma. Considering a high surgical 
risk, conservative treatment with somatostatin analogue was initiated. Follow up at 5, 10 and 
18 months revealed improved clinical status, spontaneous restauration of SR, progressive 
improvement in LVEF (30%, 33% and 40%), normalization of PAPs and of NT-proBNP = 186 
pg/ml.  
Conclusions. Here we report the case of a patient with acromegaly and severe non-ischemic 
DCM. Treatment with somatostatin analogue resulted in early improvement of clinical status 
and LV systolic function sustaining a probable causal relation between endocrinological 
dysfunction and DCM. This is a one of the few reported cases of acromegalic DCM with 
significant improvement under somatostatin analogue therapy as an initial option.  
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Background. Rheumatic mitral stenosis (MS) is associated with left atrium (LA) thrombus in 
patients in sinus rhythm (3 % – 13 %) and markedly increases in atrial fibrillation (~33 %).The 
presence of LA thrombus carries a risk of systemic embolization and neurologic morbidity. 
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The discovery of a massive thrombus through echocardiography obliges the clinicians to 
strategies for secondary prevention of trombembolic events. The main line of actions of stroke 
prevention in cardioembolism is mostly connected with antithrombotic drugs, but also other, 
more invasive. Certainly, surgery is the best solution for a successful prognostic.  
Case report. We present a case of a non-anticoagulated 56-year-old woman with severe MS. 
She was admitte to cardiology department with dyspnea, palpitations and fatigue. Anamnesis: 
10 years of atrial fibrillation (AF) and 7 years with arterial hypertension. Physical examination 
revealed an irregular pulse, at a rate of 76 beats/min. The ECG revealed an atrial fibrillation 
with a rate 75-100 b/min. ECHOCG - revealed a severe MS (V max 2.9 m/s, GP max – 33.8 
mm/hg, area – 0.5 cm2) with third degree mitral regurgitation and LA thrombus (90*80 mm), 
fixed to the upper and rear wall of the LA, third-degree tricuspid regurgitation. Left atrium was 
enlarged (59 mm), severe pulmonary arterial hypertension. The preoperative coronarography 
showed the absence of any sign of atherosclerosis. The patient was referre to cardiac surgery 
for correction of valvular pathology. Cardio-surgical intervention was performe: mechanical 
MV prosthesis ST – JUDE MED 27, DEVEGA-CABROL tricuspid annuloplasty, removing 
the massive encapsulated thrombus (90*80 mm) from the LA with the origin into the left 
appendage, obliterating the pulmonary veins, then - surgical closure of the left atrial appendage. 
After surgery, the patient had recovered well without any neurologic dysfunction in the 
postoperative period.  
Conclusions. The risk of cardioembolic complication to the patient with severe mitral valve 
stenosis is very high and depends on age and the presence of other comorbidities. Anticoagulant 
treatment in patients with severe MS and AF is paramount, cessation of anticoagulant treatment 
leads to serious complications such as stroke. In our case, the size and organized nature of the 
thrombus, prevented embolization into the systemic circulation, but in other cases the risk is 
very high. In the era of open-heart surgery and of mitral valve replacement, the prognosis for 
most patients with valvulopathies, especially those with rheumatic etiology is excellent.  
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Introduction. Myocardial bridges, parts of cardiac tissue that cover some parts of 
underepycardial coronary artery.  It is important to study their morphological and clinical 
aspects, because of their possible implication in the genesis of the coronary hemodynamic 
changes.  
Aim of the study. To determine the incidence of myocardial bridges detected by coronary 
angiography, their clinical features and management peculiarities.  
Materials and methods. We have retrospectively analyzed 6168 cases of diagnostic 
angiography and coronary angioplasty between 2013-2019. Myocardial bridges were detected 
in 357 cases (4,9%).  For the study of the clinical aspects of patients with myocardial bridges, 
only cases of angiography with myocardial bridges and coronary arteries with mild or without 
